Logo image of CE

CELANESE CORP (CE) Stock Fundamental Analysis

USA - NYSE:CE - US1508701034 - Common Stock

37.93 USD
+2.4 (+6.75%)
Last: 11/21/2025, 5:06:34 PM
37.93 USD
0 (0%)
After Hours: 11/21/2025, 5:06:34 PM
Fundamental Rating

4

CE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 82 industry peers in the Chemicals industry. CE may be in some trouble as it scores bad on both profitability and health. CE is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CE had positive earnings in the past year.
CE had a positive operating cash flow in the past year.
Of the past 5 years CE 4 years were profitable.
CE had a positive operating cash flow in each of the past 5 years.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

CE's Return On Assets of -6.83% is on the low side compared to the rest of the industry. CE is outperformed by 75.61% of its industry peers.
Looking at the Return On Equity, with a value of -30.71%, CE is doing worse than 76.83% of the companies in the same industry.
CE has a Return On Invested Capital of 3.49%. This is comparable to the rest of the industry: CE outperforms 47.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CE is in line with the industry average of 6.13%.
Industry RankSector Rank
ROA -6.83%
ROE -30.71%
ROIC 3.49%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

Looking at the Operating Margin, with a value of 9.38%, CE is in line with its industry, outperforming 54.88% of the companies in the same industry.
In the last couple of years the Operating Margin of CE has declined.
Looking at the Gross Margin, with a value of 21.85%, CE is doing worse than 60.98% of the companies in the same industry.
In the last couple of years the Gross Margin of CE has declined.
Industry RankSector Rank
OM 9.38%
PM (TTM) N/A
GM 21.85%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CE is destroying value.
The number of shares outstanding for CE has been increased compared to 1 year ago.
The number of shares outstanding for CE has been reduced compared to 5 years ago.
CE has a worse debt/assets ratio than last year.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

CE has an Altman-Z score of 1.49. This is a bad value and indicates that CE is not financially healthy and even has some risk of bankruptcy.
CE's Altman-Z score of 1.49 is on the low side compared to the rest of the industry. CE is outperformed by 65.85% of its industry peers.
CE has a debt to FCF ratio of 20.48. This is a negative value and a sign of low solvency as CE would need 20.48 years to pay back of all of its debts.
With a Debt to FCF ratio value of 20.48, CE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
CE has a Debt/Equity ratio of 2.43. This is a high value indicating a heavy dependency on external financing.
CE has a worse Debt to Equity ratio (2.43) than 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.43
Debt/FCF 20.48
Altman-Z 1.49
ROIC/WACC0.5
WACC6.98%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 2.05 indicates that CE has no problem at all paying its short term obligations.
CE has a Current ratio of 2.05. This is comparable to the rest of the industry: CE outperforms 52.44% of its industry peers.
CE has a Quick Ratio of 1.22. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CE (1.22) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.22
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for CE have decreased strongly by -47.48% in the last year.
The Earnings Per Share has been decreasing by -2.59% on average over the past years.
The Revenue has decreased by -6.03% in the past year.
Measured over the past years, CE shows a quite strong growth in Revenue. The Revenue has been growing by 10.30% on average per year.
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
Revenue 1Y (TTM)-6.03%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%

3.2 Future

CE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.09% yearly.
CE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.51% yearly.
EPS Next Y-47.45%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
EPS Next 5Y5.09%
Revenue Next Year-5.37%
Revenue Next 2Y-1.66%
Revenue Next 3Y0.05%
Revenue Next 5Y0.51%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.90, the valuation of CE can be described as very cheap.
CE's Price/Earnings ratio is rather cheap when compared to the industry. CE is cheaper than 91.46% of the companies in the same industry.
CE is valuated cheaply when we compare the Price/Earnings ratio to 25.07, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.40 indicates a rather cheap valuation of CE.
91.46% of the companies in the same industry are more expensive than CE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.08, CE is valued rather cheaply.
Industry RankSector Rank
PE 7.9
Fwd PE 6.4
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CE indicates a somewhat cheap valuation: CE is cheaper than 62.20% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CE is valued cheaply inside the industry as 93.90% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.57
EV/EBITDA 9.05
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A cheap valuation may be justified as CE's earnings are expected to decrease with -2.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.30%, CE is not a good candidate for dividend investing.
The stock price of CE dropped by -22.00% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CE's Dividend Yield is slightly below the industry average, which is at 4.00.
With a Dividend Yield of 0.30, CE pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.3%

5.2 History

The dividend of CE has a limited annual growth rate of 3.06%.
CE has been paying a dividend for at least 10 years, so it has a reliable track record.
CE has decreased its dividend recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of CE are negative and hence is the payout ratio. CE will probably not be able to sustain this dividend level.
The dividend of CE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-9.81%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

CELANESE CORP

NYSE:CE (11/21/2025, 5:06:34 PM)

After market: 37.93 0 (0%)

37.93

+2.4 (+6.75%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners107.4%
Inst Owner Change-3.69%
Ins Owners0.27%
Ins Owner Change1.72%
Market Cap4.15B
Revenue(TTM)10.28B
Net Income(TTM)-1.62B
Analysts72
Price Target55.94 (47.48%)
Short Float %7.08%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield 0.3%
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-9.81%
Div Incr Years0
Div Non Decr Years1
Ex-Date10-28 2025-10-28 (0.03)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.13%
Min EPS beat(2)-0.14%
Max EPS beat(2)44.41%
EPS beat(4)2
Avg EPS beat(4)11.14%
Min EPS beat(4)-16.92%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.27%
EPS beat(12)5
Avg EPS beat(12)1.38%
EPS beat(16)7
Avg EPS beat(16)2.17%
Revenue beat(2)1
Avg Revenue beat(2)0.76%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)2.89%
Revenue beat(4)1
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.21%
Revenue beat(12)1
Avg Revenue beat(12)-3.57%
Revenue beat(16)4
Avg Revenue beat(16)-2.02%
PT rev (1m)0.5%
PT rev (3m)-14.65%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-29.66%
EPS NY rev (1m)-2.3%
EPS NY rev (3m)-16.56%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE 7.9
Fwd PE 6.4
P/S 0.42
P/FCF 6.57
P/OCF 4.07
P/B 0.79
P/tB N/A
EV/EBITDA 9.05
EPS(TTM)4.8
EY12.65%
EPS(NY)5.92
Fwd EY15.62%
FCF(TTM)5.77
FCFY15.22%
OCF(TTM)9.32
OCFY24.56%
SpS90.77
BVpS48.18
TBVpS-36.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number72.14
Profitability
Industry RankSector Rank
ROA -6.83%
ROE -30.71%
ROCE 4.45%
ROIC 3.49%
ROICexc 3.7%
ROICexgc 6.89%
OM 9.38%
PM (TTM) N/A
GM 21.85%
FCFM 6.36%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
ROICexc(3y)4.72%
ROICexc(5y)7.67%
ROICexgc(3y)9.71%
ROICexgc(5y)12.05%
ROCE(3y)5.7%
ROCE(5y)9.11%
ROICexgc growth 3Y-25.53%
ROICexgc growth 5Y-7.04%
ROICexc growth 3Y-35.3%
ROICexc growth 5Y-15.71%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 2.43
Debt/FCF 20.48
Debt/EBITDA 7.49
Cap/Depr 49.62%
Cap/Sales 3.9%
Interest Coverage 250
Cash Conversion 59.51%
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 1.22
Altman-Z 1.49
F-Score4
WACC6.98%
ROIC/WACC0.5
Cap/Depr(3y)81.1%
Cap/Depr(5y)93.82%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
EPS Next Y-47.45%
EPS Next 2Y-15.77%
EPS Next 3Y-2.68%
EPS Next 5Y5.09%
Revenue 1Y (TTM)-6.03%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%
Revenue Next Year-5.37%
Revenue Next 2Y-1.66%
Revenue Next 3Y0.05%
Revenue Next 5Y0.51%
EBIT growth 1Y-19.24%
EBIT growth 3Y-18.82%
EBIT growth 5Y0.1%
EBIT Next Year22.28%
EBIT Next 3Y12.65%
EBIT Next 5Y9.93%
FCF growth 1Y-41.64%
FCF growth 3Y-25.61%
FCF growth 5Y-13.3%
OCF growth 1Y-39.07%
OCF growth 3Y-18.08%
OCF growth 5Y-7.85%

CELANESE CORP / CE FAQ

What is the ChartMill fundamental rating of CELANESE CORP (CE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CE.


What is the valuation status for CE stock?

ChartMill assigns a valuation rating of 7 / 10 to CELANESE CORP (CE). This can be considered as Undervalued.


What is the profitability of CE stock?

CELANESE CORP (CE) has a profitability rating of 3 / 10.


Can you provide the financial health for CE stock?

The financial health rating of CELANESE CORP (CE) is 3 / 10.


What is the expected EPS growth for CELANESE CORP (CE) stock?

The Earnings per Share (EPS) of CELANESE CORP (CE) is expected to decline by -47.45% in the next year.